Holen Sie sich die Stockscreener-App
0.6418
10.52%
0.0611
Handel nachbörslich:
.64
-0.0018
-0.28%
Schlusskurs vom Vortag:
$0.5807
Offen:
$0.58
24-Stunden-Volumen:
2.16M
Relative Volume:
0.49
Marktkapitalisierung:
$42.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-86.08M
KGV:
-0.2975
EPS:
-2.1574
Netto-Cashflow:
$-72.06M
1W Leistung:
+24.72%
1M Leistung:
-69.14%
6M Leistung:
-28.53%
1J Leistung:
-44.67%
1-Tages-Spanne:
$0.5502
$0.6421
1-Wochen-Bereich:
$0.47
$0.65
52-Wochen-Spanne:
$0.3234
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
Firmenname
Io Biotech Inc
Sektor
Branche
Telefon
(457) 070-2980
Adresse
OLE MAALOES VEH 3, COPENHAGEN
Vergleichen Sie IOBT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
0.6418 | 38.26M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-30 | Herabstufung | TD Cowen | Buy → Hold |
Io Biotech Inc Aktie (IOBT) Neueste Nachrichten
Melanoma Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Is IO Biotech Inc. stock near bottom after decline2025 Market Outlook & Growth Focused Investment Plans - newser.com
Has IO Biotech Inc. found a price floorFed Meeting & AI Powered Buy and Sell Recommendations - newser.com
Can momentum traders help lift IO Biotech Inc.Volume Spike & Weekly Watchlist for Consistent Profits - newser.com
Will IO Biotech Inc. stock outperform tech sector in 20252025 Key Lessons & Step-by-Step Trade Execution Guides - newser.com
How hedge fund analytics apply to IO Biotech Inc. stockPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
IO Biotech Inc. stock prediction for this weekMarket Volume Report & Weekly High Return Stock Forecasts - newser.com
Layoff Tracker: Ferring To Cut 500 Employees as Part of Business Model Shift - BioSpace
Candlestick signals on IO Biotech Inc. stock today2025 Sector Review & Technical Analysis for Trade Confirmation - newser.com
Does IO Biotech Inc. qualify in momentum factor screeningRisk Management & Verified Technical Signals - newser.com
Multi asset correlation models including IO Biotech Inc.Market Performance Recap & Growth Oriented Trading Recommendations - newser.com
Tick level data insight on IO Biotech Inc. volatilityEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion - Sahm
How IO Biotech Inc. stock reacts to global recession fearsEntry Point & Safe Capital Growth Trade Ideas - newser.com
How sentiment analysis helps forecast IO Biotech Inc.Earnings Performance Report & Risk Managed Trade Strategies - newser.com
What does recent volatility data suggest for IO Biotech Inc.July 2025 Setups & Consistent Growth Equity Picks - newser.com
Analysts Set IO Biotech, Inc. (NASDAQ:IOBT) Price Target at $8.00 - Defense World
Applying chart zones and confluence areas to IO Biotech Inc.Portfolio Update Summary & Long-Term Safe Investment Plans - newser.com
IO Biotech (NASDAQ:IOBT) Downgraded to Equal Weight Rating by Morgan Stanley - Defense World
IO Biotech’s (IOBT) Hold Rating Reaffirmed at TD Cowen - Defense World
IO Biotech (IOBT) Downgraded to Hold by TD Cowen | IOBT Stock Ne - GuruFocus
IO Biotech Faces Setback as FDA Opposes Cylembio BLA Submission, Morgan Stanley Says - MarketScreener
IO Biotech Feels The Heat As US FDA Dashes Cylembio Filing Hopes - insights.citeline.com
IO Biotech (NASDAQ:IOBT) Receives "Hold" Rating from TD Cowen - MarketBeat
TD Cowen Maintains IO Biotech(IOBT.US) With Hold Rating - 富途牛牛
TD Cowen Downgrades IO Biotech to Hold From Buy - MarketScreener
FDA Recommends Against IO Biotech’s Cylembio Application - The Globe and Mail
Morgan Stanley Downgrades IO Biotech to Equalweight From Overweight, Cuts Price Target to $0.39 From $4 - MarketScreener
IO Biotech stock plummets after FDA recommends against BLA submission By Investing.com - Investing.com Australia
IO Biotech (NASDAQ:IOBT) Downgraded by HC Wainwright to “Neutral” - Defense World
IO Biotech stock rating downgraded to Hold by TD Cowen on FDA setback - Investing.com Canada
IO Biotech Stock Plunges After FDA Recommends Another Trial For Investigational Cancer Vaccine - NewsBreak: Local News & Alerts
IOBT Downgraded to Neutral by HC Wainwright & Co. | IOBT Stock N - GuruFocus
IO Biotech stock downgraded to Neutral by H.C. Wainwright on trial delays - Investing.com Canada
Finanzdaten der Io Biotech Inc-Aktie (IOBT)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):